MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

AstraZeneca plc Company Profile (NYSE:AZN)

Consensus Ratings for AstraZeneca plc (NYSE:AZN) (?)
Ratings Breakdown: 4 Sell Rating(s), 5 Hold Rating(s), 10 Buy Rating(s)
Consensus Rating:Hold (Score: 2.32)
Consensus Price Target: $38.50 (17.34% upside)

Current Analysts' Coverage Summary for AstraZeneca plc (NYSE:AZN)
Show:
DateFirmActionRatingPrice TargetActions
7/2/2015Berenberg BankUpgradeHold -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/25/2015HSBCInitiated CoverageHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/9/2015Deutsche BankReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/2/2015Kepler Capital MarketsReiterated RatingReduceView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/2/2015BNP ParibasReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2015Jefferies GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/27/2015JPMorgan Chase & Co.Reiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/27/2015Citigroup Inc.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/27/2015Beaufort SecuritiesReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/14/2015BarclaysReiterated RatingUnderweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2015Credit SuisseReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/16/2015Liberum CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/15/2015Societe GeneraleInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/13/2015Shore CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/6/2015Panmure GordonReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/6/2015DanskeDowngradeSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2015SEB Equity ResearchUpgradeHold -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/22/2015Leerink SwannBoost Price Target$38.00 -> $38.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/2/2014Morgan StanleyDowngradeEqual Weight -> UnderweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/14/2014Bank of AmericaUpgradeNeutral -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2014Prime WealthReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2014Galvan ResearchReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/20/2013Bryan Garnier & CieDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/20/2013NatixisBoost Price Target$26.50 -> $28.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/16/2013Nordea Equity ResearchUpgradeSell -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/29/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha